DPP4 and type 2 diabetes mellitus: Total GLP-1ELISA and active GLP-1bioassay levels at 30 min were only 2.6- and 5.3-fold greater than that of T2DM without DPP-4 inhibitor treatment, respectively (Figures 2D,E).